- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alligator Bioscience AB (ATORX)
The Alligator Bioscience share price today is 0.2405 %REPORT_CURRENCY%, view ST ATORX stock exchange data. Track the latest Alligator Bioscience share price with real-time updates on ATORX stock performance including market cap, day range, 52-week range and dividend yield. Access ATORX charts, earnings dates and analyst estimates to support your investment decisions.
0.2405
+0.0200(+9.07%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2175
0.2775
52 wk Range
0.1570
7.2100
Earnings results expected in 10 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.21750.2775
52 wk Range
0.15707.2100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ATORX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Belgium. The company develops Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 3 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer; and ATOR-4066, tumor-directed bispecific antibody, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage for the treatment of solid metastatic tumors. It also offers ALG.APV-527, a bispecific antibody that targets the 4-1BB and 5T4 molecules, which is in phase 2 clinical trial for the treatment of solid metastatic tumors; and ATOR-1017, a monoclonal antibody that stimulates the 4-1BB receptor on T cells and NK cells in the tumor, which is in phase 1 for the treatment of solid metastatic cancers; and HLX22, an antibody that treats metastatic, gastric, and breast cancers, which is in phase 3 clinical trial. In addition, the company develops products using its technology platforms, including ALLIGATOR-GOLD, a proprietary human antibody library; ALLIGATOR-FAB, which is built on multiple scaffolds with optimal drug development properties to further increase the structural diversity of generated antibodies; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and RUBY, a bispecific antibody format. Further, it has collaboration and out-licensing agreements with Aptevo Therapeutics, Inc.; Orion Corporation.; BioArctic AB; Henlius Biotech, Inc.; and Abclon Inc. The company was incorporated in 2000 and is headquartered in Lund, Sweden.
Alligator Bioscience AB Earnings Call Summary for Q4/2025
- Alligator Bioscience reported promising phase II trial results for mitazalimab in pancreatic cancer, with 21% survival at 30 months versus 5% for standard chemotherapy
- The company maintains SEK 62.2 million in liquidity with projected quarterly costs of SEK 15-20 million for 2026, while exploring a potential SEK 61 million capital raise
- Regulatory approval was granted to partner Henlius for HLX22 Phase II/III trials in HER2-positive breast cancer, with potential royalty monetization opportunities
- Management is preparing for a phase III study of mitazalimab targeting 550 patients over 18-24 months, while actively seeking strategic partnerships to accelerate market entry
Last Updated: 12-02-2026, 08:28 pm
Read Full TranscriptCompare ATORX to Peers and Sector
Metrics to compare | ATORX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATORXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | −2.9x | −0.5x | |
PEG Ratio | −0.03 | 0.09 | 0.00 | |
Price/Book | 20.2x | 3.1x | 2.6x | |
Price / LTM Sales | 165.1x | 9.0x | 3.2x | |
Upside (Analyst Target) | 17.9% | 137.7% | 47.4% | |
Fair Value Upside | Unlock | 13.2% | 7.7% | Unlock |
Earnings
Latest Release
12-02-2026
EPS / Forecast
-0.66 / --
Revenue / Forecast
409K / --
FAQ
What Is the Alligator Bioscience (ATORX) Share Price Today?
The Alligator Bioscience share price today is 0.2405 SEK.
What is the current Alligator Bioscience (ATORX) share price and day range?
As of 25-04-2026, the Alligator Bioscience share price is 0.2405 SEK, with a previous close of 0.2205 SEK. The share price has ranged from 0.2175 to 0.2775 SEK today, while the 52-week range spans from 0.1570 to 7.2100 SEK.
What Is the Alligator Bioscience Market Cap?
As of today, Alligator Bioscience market cap is 151.0600M.
What Is the Alligator Bioscience (ATORX) Share Price Target?
The average 12-month share price target for Alligator Bioscience is 0.3000 SEK, with a high estimate of 0.3 SEK and a low estimate of 0.3 SEK. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +24.74% Upside potential.
What Is Alligator Bioscience's Earnings Per Share (TTM)?
The Alligator Bioscience EPS (TTM) is -1.8700.
When Is the Next Alligator Bioscience Earnings Date?
Alligator Bioscience will release its next earnings report on 05-05-2026.
From a Technical Analysis Perspective, Is ATORX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Alligator Bioscience Trade On?
Alligator Bioscience is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Alligator Bioscience?
The stock symbol for Alligator Bioscience is "ATORX."
How Many Times Has Alligator Bioscience Stock Split?
Alligator Bioscience has split 2 times.
How Many Employees Does Alligator Bioscience Have?
Alligator Bioscience has 11 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.